AURA

Aura Biosciences Inc · NASDAQ

Sector Health Technology
Industry Biotechnology
Website aurabiosciences.com
Employees(FY) 70
ISIN US05153U1079

Performance

-3.58%

1W

+0.14%

1M

-17.76%

3M

-9.91%

6M

-17.95%

YTD

-36.34%

1Y

Profile

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for treating tumors of high unmet need in ocular and urologic oncology. It is developing AU-011, a VDC candidate for the treatment of primary choroidal melanoma that is in phase III clinical trial. The company also develops AU-011 for additional ocular oncology indications, including choroidal metastases and is in Phase 2 dose-escalation trial. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Advanced Technical Analysis

Technical Analysis of AURA 2024-05-10

Overview:

In analyzing the technical indicators for AURA stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide yo...

See more ...

Recent News & Updates

2024-05-10 02:58
Aura Biosciences Inc (AURA) Reports Q1 2024 Earnings: A Detailed Financial Overview(Yahoo Finance)
2024-05-09 01:55
AURA Stock Earnings: Aura Biosciences Beats EPS for Q1 2024(Investorplace)
2024-05-08 19:00
Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights(Globenewswire)
2024-05-07 19:00
Aura Biosciences to Participate in Upcoming Investor Conferences(Globenewswire)
2024-03-27 01:53
AURA Stock Earnings: Aura Biosciences Beats EPS for Q4 2023(Investorplace)
2024-03-26 19:00
Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights(Businesswire)
2024-03-17 05:20
11 Oversold Biotech Stocks To Buy Right Now(Insidermonkey)
2024-02-26 07:00
Aura Biosciences to Participate in Upcoming Investor Conferences(Business Wire)
2024-02-25 18:00
Aura Biosciences to Participate in Upcoming Investor Conferences(Businesswire)
2024-01-07 07:55
Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),(Simply Wall St.)
2023-12-11 09:55
Wall Street Analysts Think Aura Biosciences, Inc. (AURA) Could Surge 174.29%: Read This Before Placing a Bet(Zacks)
2023-12-07 08:00
Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma(Business Wire)
2023-12-06 19:00
Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma(Businesswire)
2023-11-23 09:55
Wall Street Analysts Believe Aura Biosciences, Inc. (AURA) Could Rally 200.75%: Here's is How to Trade(Zacks)
2023-11-12 07:06
David Johnson Bought 232% More Shares In Aura Biosciences(Simply Wall St.)
2023-11-09 16:05
Aura Biosciences Reports Third Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights(Business Wire)
2023-11-09 03:05
Aura Biosciences Reports Third Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights(Businesswire)
2023-11-08 07:00
Aura Biosciences to Participate in Upcoming Investor Conferences(Business Wire)
2023-11-07 18:00
Aura Biosciences to Participate in Upcoming Investor Conferences(Businesswire)
2023-11-06 22:02
Aura Biosciences Announces Pricing of Public Offering of Common Stock(Business Wire)
2023-11-06 09:02
Aura Biosciences Announces Pricing of Public Offering of Common Stock(Businesswire)
2023-11-06 03:08
Aura Biosciences Announces Proposed Public Offering of Common Stock(Businesswire)
2023-11-06 02:00
Aura Biosciences Receives FDA Agreement Under Special Protocol Assessment (SPA) for CoMpass Phase 3 Clinical Trial of Belzupacap Sarotalocan (Bel-sar) in Early-stage Choroidal Melanoma(Businesswire)
2023-10-31 04:05
Aura Biosciences to Present Updated Phase 2 Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (Bel-sar) for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at AAO 2023(Businesswire)
2023-10-02 04:05
Aura Biosciences Strengthens and Expands Leadership Team with Key Appointments(Businesswire)
2023-08-08 19:00
Aura Biosciences Reports Second Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights(Yahoo Finance)
2023-07-30 18:07
Owning 38% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),(Yahoo Finance)
2023-05-24 04:05
Aura Biosciences to Participate in Upcoming Investor Conferences(Yahoo Finance)
2023-05-11 19:00
Aura Biosciences to Participate in the JMP Securities Life Sciences Conference(Yahoo Finance)
2023-05-11 04:10
Aura Biosciences Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights(Yahoo Finance)

Page 1 of 3

previousnext